Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Leukemia
  •  Chemotherapy and Radiotherapy
  •  Kidney Cancer
  •  Thoracic Oncology
  •  Urological Cancers
  •  Ovarian Cancer
  •  Bladder Cancer
  •  Paediatric Cancers


Citation: Clin Oncol. 2019;4(1):1601.DOI: 10.25107/2474-1663.1601

Achillea fragrantissima: Pharmacology Review

Jiri Patocka and Zdenka Navratilova

Department of Radiology, Toxicology and Civil Protection, University of South Bohemia in Ceske Budejovice, Czech Republic
Department of Biomedical Research, Hradec Kralove Hospital, Czech Republic
Department of Botany, Charles University, Czech Republic

*Correspondance to: Jiri Patocka 

 PDF  Full Text Review Article | Open Access


In recent years, there has been a marked increase in the popularity of medicinal plants derived from the traditional sources of knowledge. The desert plant Achillea fragrantissima is traditionally used internally in traditional medicine of the Arabian region against hepatobiliary disorders, inflammatory and spasmodic gastrointestinal complaints, against skin inflammations and for wound healing and as an appetite enhancing drug. This plant is characterized by protective antioxidative and anti-inflammatory properties. The main pharmacologically active principles were shown to be polyphenols, flavonoids, terpenes and alkamides. Aqueous and alcoholic extracts prepared from A. fragrantissima were well tolerated in acute and long-term safety studies in rats when administered orally and have a number of significant pharmacological effects, among others beneficially affects astrocytes and downregulates microglial activation.


Achillea fragrantissima; Neuroprotection; Achillolide

Cite the Article:

Patocka J, Navratilova Z. Achillea fragrantissima: Pharmacology Review. Clin Oncol. 2019; 4: 1601.

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

A Genetic Predictive Model for Precision Treatment of Diffuse Large B-Cell Lymphoma with Early Progression
 Abstract  PDF  Full Text
The Expression and Relationship of Tc17 Cells and Interleukin-27 in Local and Systemic Environment of Nonsmall Cell Lung Cancer
 Abstract  PDF  Full Text
View More...